Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
AVIR —
ATEA PHARMACEUTICALS INC
CUSIP: 04683R106 · Held by 2 superinvestors · Combined value: $4,395,352
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $4,242,945 | 1,188,500 | REDUCE | -39,400 |
| 2 | Ken Griffin | 0.0% | $152,407 | 42,691 | REDUCE | -61,538 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -39,400 | -3.2% |
| Ken Griffin | REDUCE | -61,538 | -59.0% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | NEW BUY | +104,229 | New |
| Jim Simons | REDUCE | -6,200 | -0.5% |
Who Owns AVIR? Superinvestor Holdings
ATEA PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $4 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter2 reduced or exited.